Cerniplex was studied under three separate tests. The first included 20 women with Female Sexual Disorder (FSD) and 20 normal women in a double-blind, placebo-controlled, 2-way crossover design. The placebo was matched to the active test article based on viscosity, fragrance, color, absorbency, and lubricity. At the initial screening visit subjects were interviewed by a sex therapist and underwent a physical examination. Subjects were diagnosed as "normal" or FSD based on the interview by the therapist. Subjects were asked to take Cerniplex on a daily basis for a three month period. Subjects were examined after a two month and three month period. Test results concluded that Cerniplex was safe under testing conditions. Cerniplex improves level of sexual arousal, sexual pleasure, ability to have orgasms, and enhancement of sexual experiences in normal and FSD women. Both normal and FSD women are willing to purchase Cerniplex at a significant price.
Key results are as follows:
How often do you think about sex?
0-2 Never to Almost Never | 3-4 Infrequently | 5-6 Sometimes (About half the time) |
7-8 Most times (more than half) | 9-10 Almost always of Always
How often do you feel sexually aroused during sexual activity or intercourse?
0-2 Never to Almost Never | 3-4 Infrequently | 5-6 Sometimes (About half the time) |
7-8 Most times (more than half) | 9-10 Almost always of Always
How lubricated do you become during sexual activity or intercourse?
0-2 No lubrication to very little | 3-4 Lubricated Somewhat | 5-6 Moderate Lubrication |
7-8 Substantial Lubrication | 9-10 Dramatic Lubrication
When you were sexually stimulated, how frequently did you to attain orgasm?
0-2 Never to Almost Never | 3-4 Infrequently | 5-6 Sometimes (About half the time) |
7-8 Most times (more than half) | 9-10 Almost always of Always
The second test included 20 women with irregular menstruation and very painful periods. The second group of 20 women had only painful periods and no other menstrual problems. Half the women in each group took Cerniplex for two consecutive months while the other half took the placebo. In both groups taking Cerniplex the menstrual pains either disappeared entirely or were considerably diminished in all but two women whereas only four of the twenty taking the placebo had any improvement at all.
Key results are as follows:
Percentage of menstrual pain diminished
The third and final test included 74 women aged between 40 and 55 years who, although still menstruating, were showing definite symptoms of the "change of life". 38 women took one daily capsule of Cerniplex for two consecutive months and the remaining 36 took a placebo. Of the 38 cases taking Cerniplex 35 recorded a considerable reduction in the presence of unpleasant side effects. Additionally, a most unexpected result was that of the 38 cases taking Cerniplex 20 lost weight and only 7 gained weight. 32 of the women taking Cerniplex also noted an increased sex drive.
Key results are as follows:
Percentage of diminished menapausal side effects
Cerniplex Clinical Trial prepared by Dr. Jonathan Fortuna, Midwest Sexual Performance Studies, LLC. Dr, Bogdan Tekavic, Ljubljana Center for Gynecology.
